The biology of 5-lipoxygenase: Function, structure, and regulatory mechanisms

Proceedings of the Association of American Physicians

Volumn 111, Issue 6, 1999, Pages 525-536

  Silverman, E S ^a   Drazen, J M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

5 lipoxygenase activating protein (FLAP); Early growth response protein 1 (Egr 1); Leukotriene; Polymorphism; Transcription; Translocation

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 HYDROPEROXY 6,8,11,14 ICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; LEUKOTRIENE A4;

CELL COMPARTMENTALIZATION; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STRUCTURE; GENE MUTATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; PROMOTER REGION; REGULATORY MECHANISM; REVIEW;

EID: 0032743539     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.t01-1-99231.x     Document Type: Review

References (93)

1. 1 Yamamato S. Mammalian lipoxygenases: Molecular structures and functions. Biochim. Biophys. Acta 1128: 117 131, 1992.
2. 2 Lee T.H., Mencia‐Huerta J.‐M., Shih C., et al. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5‐lipoxygenase pathway products by ionophore‐activated human neutrophils. J. Clin. Invest. 74: 1922 1933, 1984.
3. 3 Samuelsson B., Dahlen S.E., Lindgren J.A., et al. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237: 1171 1176, 1987.
4. 4 Yamamoto S., Ueda N., Yokoyama C., et al. Lipoxin syntheses by arachidonate 12‐ and 5‐lipoxygenases purified from porcine leukocytes. Adv. Exp. Med. Biol. 229: 15 26, 1988.
5. 5 Peters‐Golden M. & McNish R. Redistribution of 5‐lipoxygenase and cytosolic phospholipase A 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196: 147 153, 1993.
6. 6 Peters‐Golden M., Song K., Marshall T., Brock T. Translocation of cytosolic phospholipase A 2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochem. J. 318: 797 803, 1996.
7. 7 Dennis E. Diversity of group types, regulation, and function of phospholipase A 2. J. Biol. Chem. 269: 13057 13061, 1994.
8. 8 Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 237: 1171 1176, 1983.
9. 9 Ford‐Hutchinson A.W., Gresser M., Young R.N. 5‐Lipoxygenase. Ann. Rev. Biochem. 63: 383 417, 1994.
10. 10 Rouzer C., Matsumoto T., Samuelsson B. Single protein from leukocytes possesses 5‐lipoxygenase and leukotriene A 4 synthesis activities. Proc. Natl. Acad. Sci. U.S.A. 83: 857 861, 1986.
11. 11 Ueda N., Kaneko S., Yoshimoto T., Yamamoto S. Purification of arachidonate 5‐lipoxygenase from porcine leukocytes and its reactivity with hydroperoxyeicosatetraenoic acids. J. Biol. Chem. 261: 7982 7988, 1986.
12. 12 Murphy R. and Wheelan P. Pathways of leukotriene metabolism in isolated cell models and human subjects. In: Five Lipoxygenase Products in Asthma. Drazen J.M., Dahlen S.‐E., and Lee T.H. (eds). New York: Marcal Dekker, 1998. Pp. 87–118.
13. 13 Evans J. 5‐Lipoxygenase and 5‐lipoxygenase‐activating protein. In: Five Lipoxygenase Products in Asthma. Drazen J.M., Dahlen S.‐E., and Lee T.H. (eds). New York: Marcal Dekker, 1998. Pp. 11–26.
14. 14 Rouzer C.A. & Kargman S. Translocation of 5‐lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 263: 10980 10988, 1988.
15. 15 Pistorius E.K. & Axelrod B. Iron, an essential component of lipoxygenase. J. Biol. Chem. 249: 3183 3186, 1974.
16. 16 Denis D., Falgueyret J.P., Riendeau D., Abramovitz M. Characterization of the activity of purified recombinant human 5‐lipoxygenase in the absence and presence of leukocyte factors. J. Biol. Chem. 266: 5072 5079, 1991.
17. 17 Percival M.D. Human 5‐lipoxygenase contains an essential iron. J. Biol. Chem. 266: 10058 10061, 1991.
18. 18 Hammarberg T., Zhang Y.Y., Lind B., et al. Mutations at the C‐terminal isoleucine and other potential iron ligands of 5‐lipoxygenase. Eur. J. Biochem. 230: 401 407, 1995.
19. 19 Zhang Y.Y., Lind B., Radmark O., Samuelsson B. Iron content of human 5‐lipoxygenase, effects of mutations regarding conserved histidine residues. J. Biol. Chem. 268: 2535 2541, 1993.
20. 20 Nguyen T., Falgueyret J.P., Abramovitz M., Riendeau D. Evaluation of the role of conserved His and Met residues among lipoxygenases by site‐directed mutagenesis of recombinant human 5‐lipoxygenase. J. Biol. Chem. 266: 22057 22062, 1991.
21. 21 Hatzelmann A. & Ullrich V. Regulation of 5‐lipoxygenase activity by the glutathione status in human polymorphonuclear leukocytes. Eur. J. Biochem. 169: 175 184, 1987.
22. 22 Hatzelmann A., Schatz M., Ullrich V. Involvement of glutathione peroxidase activity in the stimulation of 5‐lipoxygenase activity by glutathione‐depleting agents in human polymorphonuclear leukocytes. Eur. J. Biochem. 180: 527 533, 1989.
23. 23 Aharony D., Redkar‐Brown D.G., Hubbs S.J., Stein R.L. Kinetic studies on the inactivation of 5‐lipoxygenase by 5 (S)‐hydroperoxyeicosatetraenoic acid. Prostaglandins 33: 85 100, 1987.
24. 24 Kargman S. & Rouzer C.A. Studies on the regulation, biosynthesis, and activation of 5‐lipoxygenase in differentiated HL60 cells. J. Biol. Chem. 264: 13313 13320, 1989.
25. 25 Lepley R.A. & Fitzpatrick F.A. Irreversible inactivation of 5‐lipoxygenase by leukotriene A 4. Characterization of product inactivation with purified enzyme and intact leukocytes. J. Biol. Chem. 269: 2627 2631, 1994.
26. 26 Schewe T., Kuhn H., Rapoport S.M. Positional specificity of lipoxygenases and their suitability for testing potential drugs. Prost. Leuk. Med. 23: 155 160, 1986.
27. 27 Rouzer C.A. & Samuelsson B. Leukocyte arachidonate 5‐lipoxygenase: Isolation and characterization. Methods Enzymol. 187: 312 319, 1990.
28. 28 Yamamato S. Mammalian lipoxygenases: Molecular structure and functions. Biochim. Biophys. Acta 1128: 117 131, 1992.
29. 29 Percival M.D., Denis D., Riendeau D., Gresser M.J. Investigation of the mechanism of non‐turnover‐dependent inactivaton of purified human 5‐lipoxygenase. Eur. J. Biochem. 210: 109 117, 1992.
30. 30 Noguchi M., Miyano M., Matsumoto T. Physiochemical characterization of ATP binding to human 5‐lipoxygenase. Lipids 31: 367 371, 1996.
31. 31 Lepley R.A., Muakardin D.T., Fitzpatrick F.A. Tyrosine kinase activity modulates catalysis and translocation of cellular 5‐lipoxygenase. J. Biol. Chem. 271: 6179 6184, 1996.
32. 32 Lepley R.A. & Fitzpatrick F.A. Inhibition of mitogen‐activated protein kinase kinase blocks activation and redistribution of 5‐lipoxygenase in HL‐60 cells. Arch. Biochem. Biophys. 331: 141 144, 1996.
33. 33 Stabel S. & Parker P.J. Protein kinase C. Pharmacol. Ther. 51: 71 95, 1991.
34. 34 Clark J.D., Lin L.‐L., Kriz R.W., et al. A novel arachidonic acid‐selective cytosolic PLA 2 contains a Ca 2+ dependent translocation domain with homology to PKC and GAP. Cell 65: 1043 1051, 1991.
35. 35 Gillard J., Ford‐Hutchinson A.W., Chan C., et al. L‐663,536(MK‐886)(3‐[1‐(4‐chlorobenzyl)‐3‐t‐butyl‐thio‐5‐isopropylindol.‐2‐yl]‐2,2‐dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. 67: 456 464, 1989.
36. 36 Miller D., Gillard J., Vickers P., et al. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343: 278 281, 1990.
37. 37 Dixon R.A., Diehl R.E., Opas E., et al. Requirement of a 5‐lipoxygenase‐activating protein for leukotriene synthesis. Nature 343: 282 284, 1990.
38. 38 Woods J.W., Coffey M.J., Brock T.G., et al. 5‐Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95: 2035 2046, 1995.
39. 39 Abramovitz M., Wong E., Cox M.E., et al. 5‐lipoxygenase‐activating protein stimulates the utilization of arachidonic acid by 5‐lipoxygenase. Eur. J. Biochem. 215: 105 111, 1993.
40. 40 Kargman S., Vickers P.J., Evans J.F. A23187‐induced translocation of 5‐lipoxygenase in osteosarcoma cells. J. Cell Biol. 119: 1701 1709, 1992.
41. 41 Mancini J.A., Abramovitz M., Cox M.E., et al. 5‐lipoxygenase‐activating protein is an arachidonate binding protein. FEBS Lett. 318: 277 281, 1993.
42. 42 Reid G.K., Kargman S., Vickers P.J., et al. Correlation between expression of 5‐lipoxygenase‐activating protein, 5‐lipoxygenase, and cellular leukotriene synthesis. J. Biol. Chem. 265: 19818 19823, 1990.
43. 43 Jakobsson P.J., Steinhilber D., Odlander B., et al. On the expression and regulation of 5‐lipoxygenase in human lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 89: 3521 3525, 1992.
44. 44 Coffey M.J., Gyetko M., Peters‐Golden M. 1,25‐Dihydroxy vitamin D3 upregulates 5‐lipoxygenase metabolism and 5‐lipoxygenase activating protein in peripheral blood monocytes as they differentiate into mature macrophages. J. Lipid Med. 6: 43 51, 1993.
45. 45 Kargman S., Rousseau P., Reid G.K., et al. Leukotriene synthesis in U937 cells expressing recombinant 5‐lipoxygenase. J. Lipid Med. 7: 31 45, 1993.
46. 46 Bennett C.F., Chiang M.Y., Monia B.P., Crooke S.T. Regulation of 5‐lipoxygenase and 5‐lipoxygenase‐activating protein expression in HL‐60 cells. Biochem. J. 289: 33 39, 1993.
47. 47 Yandava C.N., Kennedy B.P., Pillari A., et al. Cytogenetic and radiation hybrid mapping of human 5‐lipoxygenase activating protein (FLAP) to chromosome 13q12. Genomics 56: 131 133, 1999.
48. 48 Kennedy B., Diehl R., Boie Y., et al. Gene characterization and promoter analysis of the human 5‐lipoxygenase‐activating protein (FLAP). J. Biol. Chem. 266: 8511 8516, 1991.
49. 49 Griffiths R., Smith M.R., Roach M.L., et al. Collagen‐induced arthritis is reduced in 5‐lipoxygenase‐activating protein‐deficient mice. J. Exp. Med. 185: 1123 1129, 1997.
50. 50 Channon J. & Leslie C. A calcium‐dependent mechanism for associating a soluble arachidonoyl‐hydrolyzing phospholipase A 2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 265: 5409 5413, 1990.
51. 51 Woods J.W., Evans J.F., Ethier D., et al. 5‐lipoxygenase and 5‐lipoxygenase‐activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178: 1935 1946, 1993.
52. 52 Brock T.G., Paine III R., Peters‐Golden M. Localization of 5‐lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J. Biol. Chem. 269: 22059 22066, 1994.
53. 53 Peters‐Golden M. & McNish R.W. Redistribution of 5‐lipoxygenase and cytosolic phospholipase A 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196: 147 153, 1993.
54. 54 Chen X.S., Naumann T.A., Kurre U., et al. cDNA cloning, expression, mutagenesis, intracellular localization, and gene chromosomal assignment of mouse 5‐lipoxygenase. J. Biol. Chem. 270: 17993 17999, 1995.
55. 55 Wilborn J., Bailie M., Coffey M., et al. Constitutive activation of 5‐lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97: 1827 1836, 1996.
56. 56 Peters‐Golden M. Cell biology of the 5‐lipoxygenase pathway. Am. J. Respir. Crit. Care Med. 157: S227 S232, 1998.
57. 57 Rouzer C. & Samuelsson B. On the nature of the 5‐lipoxygenase reaction in human leukocytes: Enzyme purification and requirement for multiple stimulatory factors. Proc. Natl. Acad. Sci. U.S.A. 82: 6040 6044, 1985.
58. 58 Rouzer C.A., Matsumoto T., Shimizu T., Samuelsson B. The human leukocyte 5‐lipoxygenase: Enzyme purification, multi‐component regulatory system, and LTA 4 synthase activity. Adv. Prostaglandin Thromboxane Leukot. Res. 16: 3 16, 1986.
59. 59 Skoog M., Nichols J., Wiseman J. 5‐lipoxygenase from rat PMN lysate. Prostaglandins 31: 561 576, 1986.
60. 60 Aharony D. & Stein R. Kinetic mechanism of guinea pig neutrophil 5‐lipoxygenase. J. Biol. Chem. 261: 11512 11519, 1986.
61. 61 Matsumoto T., Funk C.D., Radmark O., et al. Molecular cloning and amino acid sequence of human 5‐lipoxygenase [published erratum appears in Proc. Natl. Acad. Sci. U.S.A. 85 (10):3406]. Proc. Natl. Acad. Sci. U.S.A. 85: 26 30, 1988.
62. 62 Dixon R.A., Jones R.E., Diehl R.E., et al. Cloning of the cDNA for human 5‐lipoxygenase. Proc. Natl. Acad. Sci. U.S.A. 85: 416 420, 1988.
63. 63 Rouzer C.A., Rands E., Kargman S., et al. Characterization of cloned human leukocyte 5‐lipoxygenase expressed in mammalian cells. J. Biol. Chem. 263: 10135 10140, 1988.
64. 64 Funk C.D., Gunne H., Steiner H., et al. Native and mutant 5‐lipoxygenase expression in a baculovirus/insect cell system. Proc. Natl. Acad. Sci. U.S.A. 86: 2592 2596, 1989.
65. 65 Noguchi M., Matsumoto T., Nakamura M., Noma M. Expression of human 5‐lipoxygenase cDNA in Escherichia coli. FEBS Lett. 249: 267 270, 1989.
66. 66 Nakamura M., Matsumoto T., Noguchi M., et al. Expression of a cDNA encoding human 5‐lipoxygenase under control of the STA1 promoter in Saccharomyces cerevisiae. Gene 89: 231 237, 1990.
67. 67 Balcarek J.M., Theisen T.W., Cook M.N., et al. Isolation and characterization of a cDNA clone encoding rat 5‐lipoxygenase. J. Biol. Chem. 263: 13937 13941, 1988.
68. 68 Funk C. Molecular biology in the eicosanoid field. Prog. Nucleic Acid Res. Mol. Biol. 45: 67 98, 1993.
69. 69 Lepley R.A. & Fitzpatrick F.A. 5‐Lipoxygenase contains a functional Src homology 3‐binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins. J. Biol. Chem. 269: 24163 24168, 1994.
70. 70 Lepley R. & Fitzpatrick F. 5‐lipoxygenase compartmentalization in granulocytic cells is modulated by an internal bipartite nuclear localizing sequence and nuclear factor κB complex formation. Arch. Biochem. Biophys. 356: 71 76, 1998.
71. 71 Funk C.D., Hoshiko S., Matsumoto T., et al. Characterization of the human 5‐lipoxygenase gene. Proc. Natl. Acad. Sci. U.S.A. 86: 2587 2591, 1989.
72. 72 Hoshiko S., Radmark O., Samuelsson B. Characterization of the human 5‐lipoxygenase gene promoter. Proc. Natl. Acad. Sci. U.S.A. 87: 9073 9077, 1990.
73. 73 Boado R.J., Pardridge W.M., Vinters H.V., Black K.L. Differential expression of arachidonate 5‐lipoxygenase transcripts in human brain tumors: Evidence for the expression of a multitranscript family. Proc. Natl. Acad. Sci. U.S.A. 89: 9044 9048, 1992.
74. 74 Chen X.S., Sheller J.R., Johnson E.N., Funk C.D. Role of leukotrienes revealed by targeted disruption of the 5‐lipoxygenase gene. Nature 372: 179 182, 1994.
75. 75 Goulet J.L., Snouwaert J.N., Latour A.M., et al. Altered inflammatory responses in leukotriene‐deficient mice. Proc. Natl. Acad. Sci. U.S.A. 91: 12852 12856, 1994.
76. 76 Avis I.M., Jett M., Boyle T., et al. Growth control. of lung cancer by interruption of 5‐lipoxygenase‐mediated growth factor signaling. J. Clin. Invest. 97: 806 813, 1996.
77. 77 Behera A., Kumar M., Matsuse H., et al. Respiratory syncytial virus induces the expression of 5‐lipoxygenase and endothelin‐1 in bronchial epithelial cells. Biochem. Biophys. Res. Commun. 251: 704 709, 1998.
78. 78 Bergstrom S. Prostaglandins: Members of a hormonal system. These physiologically very potent compounds of a ubiquitous occurrence are formed from essential fatty acids. Science 270: 1773 1774, 1967.
79. 79 Rosenthal M.D., Rzigalinski B.A., Blackmore P.F., Franson R.C. Cellular regulation of arachidonate mobilization and metabolism. Prostaglandins Leukot. Essent. Fatty Acids 52: 93 98, 1995.
80. 80 Ring W.L., Riddick C.A., Baker J.R., et al. Lymphocytes stimulate expression of 5‐lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony‐stimulating factor and interleukin 3. J. Clin. Invest. 97: 1293 1301, 1996.
81. 81 Steinhilber D. 5‐Lipoxygenase: Enzyme expression and regulation of activity. Pharm. Acta Helv. 69: 3 14, 1994.
82. 82 Steinhilber D., Brungs M., Radmark O., Samuelsson B. Transforming growth factor‐beta and 1,25‐dihydroxyvitamin D3 induce 5‐lipoxygenase activity during myeloid cell maturation. Adv. Prostaglandin Thromboxane Leukot. Res. 23: 449 451, 1995.
83. 83 Stankova J., Rola‐Pleszczynski M., Dubois C.M. Granulocyte‐macrophage colony‐stimulating factor increases 5‐lipoxygenase gene transcription and protein expression in human neutrophils. Blood 85: 3719 3726, 1995.
84. 84 Ponton A., Thirion J.P., Sirois P. Changes in chromatin conformation regulate the 5‐lipoxygenase gene expression during differentiation of HL60 cells. Prostaglandins Leukot. Essent. Fatty Acids. 55: 139 143, 1996.
85. 85 Ponton A., Thirion J.P., Sirois P. Repression of the 5‐lipoxygenase gene by c‐myb overexpression in differentiated HL‐60 cells. Prostaglandins 53: 49 58, 1997.
86. 86 Courey A.J. and Tjian R. Mechanisms of transcriptional control as revealed by studies of human transcription factor Sp1. In: Transcriptional Regulation, Volume 22. McKnight S.L. and Yamamoto K.R. (eds.). Cold Spring Harbor, NY: Cold Spring Harbor Press, 1992. Pp. 743–769.
87. 87 Gashler A. & Sukhatme V.P. Early growth response protein 1 (Egr‐1): Prototype of a zinc‐finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50: 191 224, 1995.
88. 88 Khachigian L.M., Lindner V., Williams A.J., Collins T. Egr‐1‐induced endothelial gene expression: A common theme in vascular injury. Science 271: 1427 1431, 1996.
89. 89 Silverman E.S., Khachigian L.M., Lindner V., et al. Inducible PDGF A‐chain transcription in smooth muscle cells is mediated by Egr‐1 displacement of Sp1 and Sp3. Am. J. Physiol. 273: H1415 H1426, 1997.
90. 90 Silverman E., Du J., Williams A., et al. cAMP‐response‐element‐binding‐protein‐binding protein (CBP) and p300 are transcriptional co‐activators of Egr‐1. Biochem. J. 336: 183 189, 1998.
91. 91 Kharabanda S., Nakamura T., Stone R., et al. Expression of the early growth response 1 and 2 zinc‐finger genes during induction of monocytic differentiation. J. Clin. Invest. 88: 571 577, 1991.
92. 92 In K.H., Asano K., Beier D., et al. Naturally occurring mutations in the human 5‐lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99: 1130–1137, 1997.
93. 93 Silverman E.S., Du J., De Sanctis G.T., et al. Egr‐1 and Sp1 interact functionally with the 5‐lipoxygenase promoter and its naturally occurring mutants. Am. J. Cell Mol. Biol. 19: 316 323, 1998.